BioFreedom
Coronary artery disease in high bleeding risk patients
CommercialMarketed (CE Mark)
Key Facts
Indication
Coronary artery disease in high bleeding risk patients
Phase
Commercial
Status
Marketed (CE Mark)
Company
About Biosensors International
Global medical device company developing innovative drug-eluting stents and balloon catheters for cardiovascular interventions.
View full company profile